TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 18:42 | 5/17/24 | SCLX | Scilex Holding Co | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | Exec Cha | P | 44 | 0.8797 | 0 | 50 | 8 | 656 | I | ||||||||||||||
9/7/22 18:22 | 9/7/22 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | See Rema | P.d | 179 | 2.02 | 0 | 89 | 1 | 7,077 | D | ||||||||||||||
9/6/22 17:24 | 9/6/22 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | See Rema | P | 109 | 1.96 | 0 | 56 | 1 | 6,989 | D | ||||||||||||||
8/26/22 17:33 | 8/26/22 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | See Rema | P.d | 70 | 2.11 | 0 | 33 | 1 | 4,433 | D | ||||||||||||||
8/25/22 17:18 | 8/25/22 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | See Rema | P.d | 46 | 2.06 | 0 | 22 | 1 | 4,400 | D | ||||||||||||||
6/14/22 17:15 | 6/14/22 | SRNE | Sorrento Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | See Rema | P | 14 | 1.40 | 0 | 10 | 0 | 4,378 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |